CALA
RhumbLine Advisers’s Calithera Biosciences, Inc CALA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-69,915
| Closed | -$169K | – | 3168 |
|
|
2021
Q1 | $169K | Sell |
69,915
-3,850
| -5% | -$9.31K | ﹤0.01% | 2868 |
|
|
2020
Q4 | $362K | Buy |
73,765
+5,530
| +8% | +$27.1K | ﹤0.01% | 2585 |
|
|
2020
Q3 | $235K | Sell |
68,235
-11,390
| -14% | -$39.2K | ﹤0.01% | 2624 |
|
|
2020
Q2 | $420K | Buy |
79,625
+2,828
| +4% | +$14.9K | ﹤0.01% | 2426 |
|
|
2020
Q1 | $341K | Buy |
76,797
+12,370
| +19% | +$54.9K | ﹤0.01% | 2342 |
|
|
2019
Q4 | $368K | Buy |
64,427
+6,014
| +10% | +$34.4K | ﹤0.01% | 2500 |
|
|
2019
Q3 | $180K | Buy |
58,413
+9,235
| +19% | +$28.5K | ﹤0.01% | 2770 |
|
|
2019
Q2 | $192K | Buy |
49,178
+1,977
| +4% | +$7.72K | ﹤0.01% | 2796 |
|
|
2019
Q1 | $318K | Buy |
47,201
+1,869
| +4% | +$12.6K | ﹤0.01% | 2517 |
|
|
2018
Q4 | $182K | Buy |
45,332
+13,612
| +43% | +$54.7K | ﹤0.01% | 2760 |
|
|
2018
Q3 | $167K | Hold |
31,720
| – | – | ﹤0.01% | 2782 |
|
|
2018
Q2 | $159K | Buy |
31,720
+3,821
| +14% | +$19.2K | ﹤0.01% | 2792 |
|
|
2018
Q1 | $176K | Sell |
27,899
-950
| -3% | -$5.99K | ﹤0.01% | 2639 |
|
|
2017
Q4 | $241K | Sell |
28,849
-5,736
| -17% | -$47.9K | ﹤0.01% | 2553 |
|
|
2017
Q3 | $545K | Buy |
34,585
+746
| +2% | +$11.8K | ﹤0.01% | 2270 |
|
|
2017
Q2 | $503K | Buy |
+33,839
| New | +$503K | ﹤0.01% | 2304 |
|
|
2016
Q2 | – | Sell |
-16,106
| Closed | -$91K | – | 3041 |
|
|
2016
Q1 | $91K | Buy |
16,106
+1,555
| +11% | +$8.79K | ﹤0.01% | 2911 |
|
|
2015
Q4 | $111K | Buy |
14,551
+675
| +5% | +$5.15K | ﹤0.01% | 2938 |
|
|
2015
Q3 | $75K | Buy |
13,876
+736
| +6% | +$3.98K | ﹤0.01% | 2971 |
|
|
2015
Q2 | $94K | Buy |
+13,140
| New | +$94K | ﹤0.01% | 3012 |
|